CN Patent

CN116270551A — 通过盐至中性药物原位转化的组合物、透皮贴剂及应用

Assigned to Corian Co ltd · Expires 2023-06-23 · 3y expired

What this patent protects

本发明涉及通过盐至中性药物原位转化的组合物、透皮贴剂及应用，提供了用于透皮给予盐形式而不是中性形式的活性剂的组合物、装置和方法。

USPTO Abstract

本发明涉及通过盐至中性药物原位转化的组合物、透皮贴剂及应用，提供了用于透皮给予盐形式而不是中性形式的活性剂的组合物、装置和方法。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN116270551A
Jurisdiction: CN
Classification: —
Expires: 2023-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Corian Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.